NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
The prevalence of non-alcoholic fatty liver disease (NAFLD) has been increasing rapidly and at the forefront of worldwide concern. Characterized by excessive fat accumulation in the liver, NAFLD regularly coexists with metabolic disorders, including type 2 diabetes, obesity, and cardiovascular disea...
Main Authors: | Ming-Feng Xia, Hua Bian, Xin Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00877/full |
Similar Items
-
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
by: Seogsong Jeong, et al.
Published: (2023-03-01) -
Treatments for NAFLD: State of Art
by: Alessandro Mantovani, et al.
Published: (2021-02-01) -
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
by: Xuefeng Ma, et al.
Published: (2020-01-01) -
Genetic implications in patients with NAFLD
by: Jakub Misiak, et al.
Published: (2024-01-01) -
NAFLD: Mechanisms, Treatments, and Biomarkers
by: Fatiha Nassir
Published: (2022-06-01)